| Cannabis use: signal of increasing risk of serious cardiovascular disorders E Jouanjus, M Lapeyre‐Mestre, J Micallef, ... Journal of the American Heart Association 3 (2), e000638, 2014 | 220 | 2014 |
| Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double‐blind controlled study in general practice N Nguyen, E Fakra, V Pradel, E Jouve, C Alquier, ME Le Guern, J Micallef, ... Human Psychopharmacology: Clinical and Experimental 21 (3), 139-149, 2006 | 193 | 2006 |
| Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case–noncase study in the French Pharmacovigilance Database J Béné, G Moulis, I Bennani, M Auffret, P Coupe, S Babai, D Hillaire‐Buys, ... British Journal of Dermatology 175 (2), 296-301, 2016 | 181 | 2016 |
| Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial J Micallef, S Attarian, O Dubourg, PM Gonnaud, JY Hogrel, T Stojkovic, ... The Lancet Neurology 8 (12), 1103-1110, 2009 | 161 | 2009 |
| An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth … S Attarian, JM Vallat, L Magy, B Funalot, PM Gonnaud, A Lacour, ... Orphanet journal of rare diseases 9, 1-15, 2014 | 149 | 2014 |
| Impact of a prescription monitoring program on doctor‐shopping for high dosage buprenorphine V Pradel, E Frauger, X Thirion, E Ronfle, V Lapierre, A Masut, C Coudert, ... Pharmacoepidemiology and drug safety 18 (1), 36-43, 2009 | 139 | 2009 |
| A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis M Kilani, J Micallef, C Soubrouillard, D Rey‐Lardiller, C Demattei, M Dib, ... Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 5 (1), 46-54, 2004 | 138 | 2004 |
| Neurobiology and clinical pharmacology of obsessive-compulsive disorder J Micallef, O Blin Clinical neuropharmacology 24 (4), 191-207, 2001 | 137 | 2001 |
| Yawning G Daquin, J Micallef, O Blin Sleep medicine reviews 5 (4), 299-312, 2001 | 128 | 2001 |
| French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP-A) Working Group on Cannabis Complications E Jouanjus, M Lapeyre-Mestre, J Micallef Cannabis use: signal of increasing risk of serious cardiovascular disorders …, 2014 | 125 | 2014 |
| Buprenorphine prescription by general practitioners in a French region X Thirion, V Lapierre, J Micallef, E Ronfle, A Masut, V Pradel, C Coudert, ... Drug and alcohol dependence 65 (2), 197-204, 2002 | 116 | 2002 |
| The drugs that mostly frequently induce acute kidney injury: a case− noncase study of a pharmacovigilance database M Pierson‐Marchandise, V Gras, J Moragny, J Micallef, L Gaboriau, ... British journal of clinical pharmacology 83 (6), 1341-1349, 2017 | 114 | 2017 |
| Antipsychotic-associated weight gain and clinical outcome parameters O Blin, J Micallef Journal of Clinical Psychiatry 62, 11-21, 2001 | 109 | 2001 |
| Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection J Micallef, T Soeiro, AP Jonville-Bera, FS of Pharmacology Therapies 75 (4), 355-362, 2020 | 108 | 2020 |
| Assessment of abuse potential of benzodiazepines from a prescription database using ‘doctor shopping’as an indicator V Pradel, C Delga, F Rouby, J Micallef, M Lapeyre-Mestre CNS drugs 24, 611-620, 2010 | 104 | 2010 |
| A double blind parallel group placebo controlled comparison of sedative and amnesic effects of etifoxine and lorazepam in healthy subjects. J Micallef, C Soubrouillard, F Guet, ME Le Guern, C Alquier, ... Fundamental & clinical pharmacology 15 (3), 2001 | 103 | 2001 |
| Assessment of doctor‐shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database V Pradel, X Thirion, E Ronfle, A Masut, J Micallef, B Bégaud Pharmacoepidemiology and drug safety 13 (7), 473-481, 2004 | 97 | 2004 |
| Weight gain profiles of new anti‐psychotics: public health consequences S Tardieu, J Micallef, S Gentile, O Blin Obesity reviews 4 (3), 129-138, 2003 | 88 | 2003 |
| Doctor shopping reveals geographical variations in opioid abuse P Addictovigilance, A Midi-Pyrénées, F de Toulouse, J Micallef, ... Pain physician 16, 89-100, 2013 | 84 | 2013 |
| Comparison of methadone and high dosage buprenorphine users in French care centres K Barrau, X Thirion, J Micallef, C Chuniaud‐Louche, B Bellemin, ... Addiction 96 (10), 1433-1441, 2001 | 80 | 2001 |
